TrialNet Locations

With more than 200 locations offering Pathway to Prevention screening and the option to get a test kit in the mail to take to a local lab, it’s easy to participate. These Centers coordinate all the TrialNet sites in their geographical region.

Find a Location

from

United States

University of Florida Logo

University of Florida

Gainesville, FL

The University of Florida (UF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Desmond Schatz, MD, the TrialNet team at UF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Miami

Diabetes Research Institute

Miami, FL

University of Miami is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by David Baidal, MD, the TrialNet team at University of Miami is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Minnesota

Minneapolis, MN

University of Minnesota is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Antoinette Moran, MD, the TrialNet team at University of Minnesota is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Pittsburgh

University of Pittsburgh at UPMC Children’s Hospital of Pittsburgh

Pittsburgh, PA

University of Pittsburgh is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Dorothy Becker, MD, the TrialNet team at University of Pittsburgh is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis. Our center is located at the Children's Hospital of Pittsburgh of UPMC.

University of South Florida

Tampa, FL

University of South Florida (USF) is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Henry Rodriguez, MD, the TrialNet team at USF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Texas Southwestern

Dallas, TX

University of Texas Southwestern (UTSW) is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Philip Raskin, MD, the TrialNet team at UTSW is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Vanderbilt University Medical Center

Nashville, TN

Vanderbilt University Medical Center is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Bill Russell, MD, the TrialNet team at Vanderbilt is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Yale University

Yale Center for Clinical Investigation

New Haven, CT

Yale is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by our Clinical Center Director and Principal Investigator, Kevan Herold, MD, the TrialNet team at Yale is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Sweden

Skane

Lund University

Department of Clinical Sciences Malmö Division of Diabetes & Celiac Disease

Malmö, SE

Skane University is one of twenty five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research also serving Denmark. Led by Åke Lernmark, the TrialNet team at Skane University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Italy

Vita-Salute San Raffaele University

Milan, MI

San Raffaele Hospital is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Emanuele Bosi, MD, the TrialNet team at San Raffaele Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Pages